stockrowIronwood Pharmaceuticals, Inc.
IRWD Healthcare Drug Manufacturers Specialty & Generic
Ironwood Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $296.2 million, down 15.7% from fiscal 2024.
- Revenue
- +9.00%
- EPS
- +44.0%
- Free cash flow
- +41.7%
- Total debt
- 0.00%
Quarter to September 2026, against a year earlier
Follow IRWD
Alert me
Ironwood Pharmaceuticals, Inc. (IRWD) P/E ratio
As of 5 November 2026, Ironwood Pharmaceuticals, Inc. (IRWD) trades at a P/E ratio of 4.3×. Over the past ten years it has ranged from 0.0× (September 2025) to 129× (July 2024); the current reading is higher than 70% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 20.5× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 21.4× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 10.8× | 200.93% |
| FY2021 | 3.6× | (78.96%) |
| FY2020 | 17.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 4.4× | (17.13%) |
| Jun 2026 | 5.3× | (4.12%) |
| Mar 2026 | 5.5× | (74.26%) |
| Dec 2025 | 21.4× | 201.16% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TKNO Alpha Teknova, Inc. compare | n/m |
| HROW Harrow, Inc. compare | n/m |
| AQST Aquestive Therapeutics, Inc. compare | n/m |
| EVO Evotec AG compare | n/m |
| TLRY Tilray Brands, Inc. compare | n/m |
| EOLS Evolus, Inc. compare | n/m |
| IRWD Ironwood Pharmaceuticals, Inc. | 4.3× |
| KMDA Kamada Ltd. compare | 18.1× |
| COLL Collegium Pharmaceutical, Inc. compare | 20.5× |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)